+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Spectral analysis of the electro encephalogram in hepatic encephalopathy treated with l dopa

Electroencephalography & Clinical Neurophysiology 52(6): 617-625
Spectral analysis of the electro encephalogram in hepatic encephalopathy treated with l dopa
A marked increase in low frequencies is the hallmark of the EEG changes in hepatic encephalopathy (HE). These changes are the best known correlates to the clinical state. In HE cases, dramatic clinical and EEG improvements were observed in response to L-dopa treatment. Frequency analysis was performed of EEG records that had been taken in acute HE and EEG power values before treatment were compared to power values during lactulose-neomycin-L-dopa treatment, when clinical and EEG improvement occurred. Nine cases were recorded both before and during treatment, 6 were recorded only before and 1 case only during treatment. The power-spectral calculations were performed on long time segments with overlaying and averaging, and a special data window (Blackman-Harris 4 sample window) was used, in order to increase resolution. There was a marked and significant decrease in the low-frequencies power in response to treatment, which also correlated well with clinical improvement. The .alpha. and .beta. frequencies power was not affected either by the HE dysmetabolic state, or by the treatment and did not correlate at all with the clinical improvement. The slow-wave generating processes may in fact be activated by the HE dysmetabolic states, and that this phenomenon may not be due to slowing of the .alpha. and the .beta. generating processes. These last processes did not respond to the dysmetabolic state, nor did they respond to the treatment with high doses of L-dopa. The .alpha. and .beta. generating processes are probably neither dopaminergic nor serotoninergic. It seems that the slow-wave generating processes are L-dopa responders. All cases were treated with lactulose and neomycin as well as L-dopa, and reduction of slow-waves may be attributed to the metabolic improvement and not to the direct effect of L-dopa.

Accession: 006459453

Related references

Quantitative analysis of electro encephalogram power spectra in experimental hepatic encephalopathy. Neuropsychobiology 9(4): 235-243, 1983

Electro encephalogram operant conditioning in a monkey model part 2 electro encephalogram spectral analysis. Epilepsia 18(4): 481-488, 1977

Hepatic encephalopathy electro encephalogram and octopamine. Journal of Clinical Psychiatry 41(5): 175-177, 1980

Electro encephalogram power spectral changes secondary to l dopa treatment in parkinsonian patients a pilot study. Electroencephalography and Clinical Neurophysiology 43(1): 111-118, 1977

Electro encephalography and hemo dialysis a structural survey of electro encephalographic spectral analysis hjorths electro encephalogram descriptors blood variables and psychological data. Electroencephalography and Clinical Neurophysiology 43(6): 787-797, 1977

Spectral analysis of the EEG in hepatic encephalopathy treated with levodopa. Electroencephalography and Clinical Neurophysiology 52(6): 617-625, 1981

Effect of bromocriptine therapy on the electro encephalogram in chronic hepatic encephalopathy. Clinical Electroencephalography 14(2): 86-89, 1983

Spectral and coherence analysis of simultaneous electro encephalogram and electro myogram during activity. Federation Proceedings 31(2): 404, 1972

Electro encephalogram electro myogram and continuous spectral analysis in neurological intensive monitoring. Electroencephalography & Clinical Neurophysiology 56(3): S210, 1983

Spectral analysis of the electro encephalogram comparison of various spectral parameters. Electroencephalography & Clinical Neurophysiology 52(2): 218-221, 1981